Clinically, GLP-1 agonists appear to have a broadly beneficial impact on cancer prevention as supported by this report
In the STEP UP trial, participants achieved average weight loss of approximately 20.7% after 72 weeks, with more than one-third losing at least 25% of their starting body weight
Carnitine, creatine, or both
The fasting blood glucose was also taken in a relaxed condition using a finger prick blood sample and measured using a Kiptrack blood glucose monitor (MedNet GmbH Borkstrae 10, 48,163 Mnster, Germany)
Providers should take the time to reassure patients and educate them about what to expect while on semaglutide
An everything-but-the-kitchen-sink mapping study of GLP1- receptor agonists compared to other diabetes medications, where 175 health outcomes were assessed between the two groups, was published this year and it highlighted a number of slight risk increases with GLP-1 receptor agonists